Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Work
Year: 2016
Type: article
Abstract: Ixazomib is an oral proteasome inhibitor that is currently being studied for the treatment of multiple myeloma.
Source: New England Journal of Medicine
Institutions Hotel Dieu Hospital, Unified Szent István and Szent László Hospital, Semmelweis University, Medical University of Lublin, University of Calgary +17 more
Cites: 32
Cited by: 961
Related to: 10
FWCI: 97.64
Citation percentile (by year/subfield): 99.99
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze